Monica Rimoldi1, Marcello Chieppa2, 7, Valentina Salucci1, Francesca Avogadri1, Angelica Sonzogni3, Gianluca M Sampietro4, Angelo Nespoli5, Giuseppe Viale3, 6, Paola Allavena2
& Maria Rescigno11
Department of Experimental Oncology, European Institute of Oncology, I-20141 Milan, Italy.
2
Department of Immunology, Istituto di Ricerche Farmacologiche 'Mario Negri', 20157 Milan, Italy.
3
Department of Pathology and Laboratory Medicine, European Institute of Oncology, I-20141 Milan, Italy.
4
Division of General Surgery, University of Milan and Luigi Sacco Hospital, Milan 20157, Italy.
5
University of Milano-Bicocca and San Gerardo Hospital, Monza, Milan 20052, Italy.
6
University of Milan School of Medicine, Milan 20141, Italy.
7
Present address: Laboratory of Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Correspondence should be addressed to Maria Rescigno maria.rescigno@ifom-ieo-campus.it
